UBS Maintains Buy on MetLife, Raises Price Target to $102

Benzinga Newsdesk www.benzinga.com Positive 70.4%

Neg 0% Neu 0% Pos 70.4%

UBS analyst Michael Ward maintains MetLife (NYSE:MET) with a Buy and raises the price target from $98 to $102.

Comments

No comments yet. Be the first!